Diopsysfounded In 1998 And Based In Pine Brooknew Jerseyis A Medical Device Company That Specializes In Visual Electrophysiology Technologiesacquired By Lumithera In November 2021Diopsys Focuses On Developing Objectivefunctional Vision Testing Systems To Assist In The Early Detection And Management Of Vision Disordersthe Company Serves Eye Care Professionals Globallyproviding Essential Tools For Diagnosing Conditions Such As Glaucoma And Amblyopia Diopsys Offers A Range Of Non Invasive Vision Testing Devicesincluding The Diopsysanova Vep Vision Testing Systemwhich Detects Amblyopia And Other Vision Disorders Using Advanced Visually Evoked Potential Technologythe Argos System Provides Objective Data To Assess Retinal And Neural Pathway Functionwith A Strong Emphasis On Innovationdiopsys Holds Multiple Patentsincluding One For A Vision Examination System That Enhances Vep Waveform Analysisthe Company Is Committed To Improving Patient Outcomes Through Its Advanced Testing Solutions
